| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
99,245 |
87,785 |
$4.60M |
| 0682 |
|
1,113 |
1,110 |
$3.94M |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
21,665 |
1,817 |
$2.58M |
| 0510 |
|
61,701 |
53,078 |
$1.89M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,428 |
7,172 |
$1.79M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,106 |
14,982 |
$1.47M |
| J0882 |
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
5,498 |
1,485 |
$1.17M |
| Z7502 |
|
32,605 |
32,070 |
$1.16M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
10,225 |
9,135 |
$987K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,164 |
11,272 |
$985K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12,815 |
12,441 |
$870K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
7,703 |
7,218 |
$794K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
7,701 |
7,570 |
$762K |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,893 |
8,432 |
$739K |
| 80053 |
Comprehensive metabolic panel |
71,048 |
65,683 |
$696K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
24,737 |
21,479 |
$696K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
11,659 |
11,005 |
$684K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
28,272 |
26,145 |
$665K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
79,522 |
72,499 |
$586K |
| 0761 |
|
19,816 |
17,184 |
$537K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13,323 |
13,074 |
$509K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,921 |
3,781 |
$506K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,187 |
3,172 |
$497K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12,289 |
12,056 |
$482K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,847 |
8,979 |
$477K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,609 |
2,563 |
$475K |
| 0250 |
|
65,028 |
31,342 |
$433K |
| 0683 |
|
691 |
644 |
$412K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
9,698 |
9,407 |
$396K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,494 |
7,587 |
$371K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,111 |
10,152 |
$347K |
| 71046 |
Radiologic examination, chest; 2 views |
17,301 |
16,367 |
$338K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,550 |
2,484 |
$335K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,161 |
6,976 |
$324K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,891 |
3,684 |
$311K |
| 71045 |
Radiologic examination, chest; single view |
26,155 |
24,164 |
$310K |
| J3490 |
Unclassified drugs |
30,553 |
13,241 |
$300K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,886 |
1,835 |
$299K |
| Z7500 |
|
8,886 |
7,945 |
$291K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,066 |
3,598 |
$281K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
4,752 |
4,616 |
$272K |
| Z9725 |
|
6,324 |
6,210 |
$272K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,318 |
5,186 |
$269K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,141 |
1,122 |
$268K |
| 83880 |
|
7,404 |
6,961 |
$259K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,324 |
3,034 |
$254K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,097 |
2,991 |
$252K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,464 |
4,013 |
$232K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,321 |
4,176 |
$230K |
| 0360 |
|
3,337 |
3,257 |
$229K |
| 84484 |
|
18,169 |
16,569 |
$201K |
| 70486 |
|
1,773 |
1,714 |
$197K |
| 76830 |
Ultrasound, transvaginal |
3,105 |
3,002 |
$188K |
| 71250 |
|
1,378 |
1,337 |
$180K |
| 70498 |
|
834 |
826 |
$178K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,920 |
1,914 |
$178K |
| J1756 |
Injection, iron sucrose, 1 mg |
4,559 |
1,005 |
$174K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
924 |
905 |
$167K |
| Z7610 |
|
18,325 |
11,416 |
$165K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
5,775 |
5,729 |
$165K |
| 0160 |
|
481 |
344 |
$164K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,100 |
2,095 |
$163K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
21,047 |
9,811 |
$163K |
| 92557 |
|
2,036 |
2,029 |
$160K |
| 76801 |
|
2,464 |
2,154 |
$151K |
| 0760 |
|
6,821 |
6,096 |
$147K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
598 |
576 |
$144K |
| 93971 |
|
1,439 |
1,388 |
$144K |
| 93970 |
|
855 |
848 |
$138K |
| 70496 |
|
635 |
629 |
$134K |
| 84443 |
Thyroid stimulating hormone (TSH) |
13,166 |
12,933 |
$125K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,525 |
9,963 |
$125K |
| J1644 |
Injection, heparin sodium, per 1000 units |
9,074 |
983 |
$120K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,542 |
1,526 |
$116K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
358 |
344 |
$115K |
| 81001 |
|
35,881 |
33,687 |
$115K |
| 73610 |
|
5,224 |
4,807 |
$109K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
1,587 |
131 |
$108K |
| 0762 |
|
519 |
445 |
$107K |
| 73130 |
|
5,295 |
4,909 |
$106K |
| 84702 |
|
7,397 |
6,653 |
$102K |
| 86141 |
|
7,871 |
7,627 |
$100K |
| 90715 |
|
2,211 |
2,195 |
$100K |
| 83690 |
|
13,591 |
12,739 |
$99K |
| 87634 |
|
1,204 |
1,164 |
$99K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,508 |
1,328 |
$97K |
| 73110 |
|
4,487 |
4,124 |
$95K |
| 78451 |
|
723 |
712 |
$94K |
| 73630 |
|
4,545 |
4,353 |
$92K |
| 87088 |
|
14,240 |
13,575 |
$92K |
| 76770 |
|
1,399 |
1,374 |
$91K |
| 76641 |
|
1,241 |
1,212 |
$90K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,027 |
1,257 |
$87K |
| 83605 |
|
6,687 |
6,228 |
$83K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
395 |
365 |
$81K |
| 87040 |
|
4,385 |
4,179 |
$81K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,315 |
2,102 |
$80K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,209 |
1,186 |
$78K |
| Z6006 |
|
2,490 |
212 |
$78K |
| 72170 |
|
3,867 |
3,747 |
$77K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,037 |
999 |
$77K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,008 |
2,890 |
$76K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,079 |
1,356 |
$74K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,965 |
6,478 |
$74K |
| 73030 |
|
3,301 |
3,178 |
$67K |
| 94729 |
|
1,352 |
1,313 |
$67K |
| 90378 |
|
39 |
24 |
$66K |
| 73560 |
|
4,448 |
4,253 |
$66K |
| 83735 |
|
9,910 |
8,796 |
$65K |
| 72131 |
|
456 |
442 |
$63K |
| 85610 |
|
17,145 |
16,092 |
$62K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,874 |
3,696 |
$61K |
| 92588 |
|
1,034 |
1,033 |
$61K |
| 94726 |
|
1,333 |
1,291 |
$61K |
| 72141 |
|
299 |
284 |
$59K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,645 |
2,440 |
$59K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,134 |
1,123 |
$58K |
| 84145 |
|
2,099 |
2,044 |
$58K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
814 |
805 |
$54K |
| 99215 |
Prolong outpt/office vis |
796 |
766 |
$53K |
| 92587 |
|
1,078 |
1,071 |
$51K |
| 85730 |
|
8,660 |
8,416 |
$51K |
| 74018 |
|
2,399 |
2,328 |
$51K |
| 0710 |
|
2,164 |
2,133 |
$50K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,603 |
5,517 |
$49K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
628 |
618 |
$49K |
| 72100 |
|
1,905 |
1,874 |
$48K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,196 |
1,117 |
$48K |
| 0361 |
|
368 |
355 |
$47K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,339 |
1,314 |
$46K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,542 |
1,541 |
$45K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,167 |
4,142 |
$45K |
| 94060 |
|
1,232 |
1,195 |
$44K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,843 |
5,672 |
$44K |
| 73590 |
|
2,494 |
2,325 |
$44K |
| 81025 |
|
12,280 |
11,716 |
$44K |
| 87070 |
|
5,141 |
5,061 |
$43K |
| 92550 |
|
1,919 |
1,912 |
$43K |
| 82948 |
|
8,891 |
5,806 |
$43K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
257 |
256 |
$43K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,461 |
3,888 |
$42K |
| 73502 |
|
1,276 |
1,230 |
$42K |
| 73562 |
|
2,082 |
2,022 |
$40K |
| 73070 |
|
2,250 |
2,068 |
$40K |
| 99243 |
|
493 |
486 |
$38K |
| 73090 |
|
1,831 |
1,693 |
$36K |
| 86481 |
|
616 |
613 |
$34K |
| 95811 |
|
162 |
135 |
$34K |
| 72040 |
|
1,391 |
1,332 |
$34K |
| 96367 |
|
677 |
632 |
$34K |
| 86780 |
|
2,906 |
2,723 |
$33K |
| 0700 |
|
769 |
682 |
$31K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,552 |
4,086 |
$31K |
| 87077 |
|
3,616 |
3,513 |
$29K |
| 87186 |
|
3,443 |
3,340 |
$29K |
| 93000 |
|
661 |
620 |
$29K |
| 0750 |
|
250 |
247 |
$29K |
| 76536 |
|
537 |
529 |
$28K |
| 86703 |
|
4,429 |
4,404 |
$27K |
| 80061 |
Lipid panel |
9,350 |
9,289 |
$26K |
| 59025 |
Fetal non-stress test |
1,665 |
1,453 |
$26K |
| 84439 |
|
5,402 |
5,310 |
$25K |
| J2785 |
Injection, regadenoson, 0.1 mg |
408 |
401 |
$25K |
| 80143 |
|
1,207 |
1,141 |
$25K |
| 73552 |
|
1,007 |
972 |
$25K |
| 96415 |
|
549 |
366 |
$24K |
| 82728 |
|
3,144 |
3,054 |
$24K |
| 0270 |
|
1,689 |
1,454 |
$24K |
| 86803 |
|
3,959 |
3,929 |
$23K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,283 |
10,199 |
$23K |
| 73140 |
|
1,475 |
1,365 |
$22K |
| 85379 |
|
1,963 |
1,940 |
$21K |
| 86850 |
|
5,926 |
5,687 |
$21K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,210 |
1,980 |
$20K |
| J0636 |
Injection, calcitriol, 0.1 mcg |
1,760 |
179 |
$19K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
641 |
636 |
$19K |
| 99205 |
Prolong outpt/office vis |
168 |
168 |
$18K |
| 86901 |
|
6,030 |
5,782 |
$18K |
| 73221 |
|
91 |
87 |
$18K |
| 0272 |
|
820 |
798 |
$18K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
138 |
84 |
$18K |
| 86900 |
|
6,036 |
5,787 |
$18K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,849 |
2,033 |
$17K |
| 97750 |
|
394 |
199 |
$17K |
| 77066 |
Tomosynthesis, mammo |
130 |
130 |
$17K |
| 90686 |
|
822 |
811 |
$17K |
| 76870 |
|
406 |
391 |
$16K |
| 96368 |
|
622 |
604 |
$16K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
684 |
627 |
$16K |
| 82550 |
|
2,488 |
2,384 |
$16K |
| 93271 |
|
214 |
214 |
$16K |
| 87340 |
|
3,619 |
3,567 |
$15K |
| 85651 |
|
5,791 |
5,667 |
$15K |
| 86480 |
|
480 |
476 |
$15K |
| 92570 |
|
491 |
490 |
$14K |
| 73060 |
|
715 |
663 |
$14K |
| 80069 |
|
3,207 |
2,882 |
$14K |
| 71271 |
|
123 |
121 |
$14K |
| 72114 |
|
284 |
277 |
$14K |
| 93017 |
|
252 |
249 |
$14K |
| 94664 |
|
1,234 |
1,203 |
$13K |
| 87632 |
|
95 |
91 |
$13K |
| J1453 |
Injection, fosaprepitant, 1 mg |
43 |
26 |
$13K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
407 |
389 |
$13K |
| 85027 |
|
4,583 |
2,823 |
$13K |
| 82607 |
|
2,090 |
2,074 |
$13K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
38 |
38 |
$12K |
| J2060 |
Injection, lorazepam, 2 mg |
1,601 |
1,430 |
$12K |
| 86706 |
|
2,814 |
2,781 |
$11K |
| 73565 |
|
674 |
658 |
$11K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
441 |
382 |
$10K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,941 |
1,853 |
$10K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,427 |
1,365 |
$10K |
| 83970 |
|
907 |
868 |
$10K |
| 70491 |
|
54 |
53 |
$9K |
| 74174 |
|
27 |
26 |
$9K |
| 82553 |
|
886 |
821 |
$9K |
| 97014 |
|
693 |
295 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
335 |
329 |
$9K |
| 95816 |
|
95 |
91 |
$9K |
| 97010 |
|
734 |
358 |
$8K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,082 |
2,553 |
$8K |
| 0636 |
|
963 |
821 |
$8K |
| 88304 |
|
307 |
293 |
$8K |
| 72128 |
|
54 |
54 |
$7K |
| 86705 |
|
1,344 |
1,329 |
$7K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
488 |
454 |
$7K |
| 83550 |
|
2,269 |
2,208 |
$7K |
| 81002 |
|
3,190 |
2,999 |
$7K |
| 98966 |
|
625 |
492 |
$7K |
| 84100 |
|
1,803 |
1,670 |
$7K |
| J1815 |
Injection, insulin, per 5 units |
717 |
441 |
$6K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
360 |
209 |
$6K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
49 |
49 |
$6K |
| 73020 |
|
409 |
388 |
$6K |
| 82150 |
|
885 |
868 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
948 |
883 |
$6K |
| 86255 |
|
779 |
769 |
$6K |
| 86704 |
|
1,180 |
1,169 |
$6K |
| 93793 |
|
394 |
267 |
$6K |
| 92582 |
|
120 |
120 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
11,122 |
10,851 |
$5K |
| 93226 |
|
113 |
110 |
$5K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
294 |
261 |
$5K |
| 97139 |
|
211 |
49 |
$5K |
| 84481 |
|
586 |
573 |
$5K |
| 12002 |
|
296 |
293 |
$5K |
| 99242 |
|
65 |
64 |
$5K |
| 99000 |
|
1,600 |
1,428 |
$4K |
| 12001 |
|
276 |
274 |
$4K |
| J1953 |
Injection, levetiracetam, 10 mg |
148 |
133 |
$4K |
| 86235 |
|
628 |
559 |
$4K |
| 82805 |
|
146 |
144 |
$4K |
| 82746 |
|
534 |
529 |
$4K |
| 36000 |
|
798 |
789 |
$4K |
| 93225 |
|
111 |
111 |
$4K |
| 72110 |
|
98 |
98 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
132 |
131 |
$4K |
| 80076 |
|
849 |
839 |
$4K |
| Z7506 |
|
261 |
252 |
$4K |
| 87081 |
|
691 |
687 |
$3K |
| 87147 |
|
810 |
796 |
$3K |
| 83615 |
|
592 |
567 |
$3K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
133 |
121 |
$3K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
111 |
108 |
$3K |
| 92551 |
|
218 |
218 |
$3K |
| 87210 |
|
672 |
659 |
$3K |
| 82565 |
|
952 |
856 |
$3K |
| 86708 |
|
607 |
604 |
$3K |
| 82009 |
|
566 |
505 |
$3K |
| 87807 |
|
236 |
234 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
94 |
94 |
$3K |
| 82946 |
|
149 |
142 |
$3K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
101 |
101 |
$2K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
226 |
189 |
$2K |
| 83721 |
|
1,906 |
1,894 |
$2K |
| 84520 |
|
1,930 |
1,585 |
$2K |
| 87400 |
|
292 |
288 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
25 |
25 |
$2K |
| 97035 |
|
248 |
135 |
$2K |
| 36600 |
|
285 |
276 |
$2K |
| 97032 |
|
206 |
117 |
$2K |
| 82951 |
|
133 |
124 |
$2K |
| 77062 |
|
15 |
13 |
$2K |
| 97116 |
|
114 |
52 |
$2K |
| 76000 |
|
94 |
76 |
$2K |
| 74022 |
|
54 |
54 |
$2K |
| 81015 |
|
782 |
755 |
$2K |
| 73700 |
|
12 |
12 |
$2K |
| 84550 |
|
763 |
751 |
$2K |
| Z7504 |
|
32 |
26 |
$2K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
54 |
54 |
$2K |
| 87205 |
|
580 |
575 |
$2K |
| 82043 |
|
2,194 |
2,179 |
$2K |
| 12011 |
|
53 |
52 |
$1K |
| 76881 |
|
20 |
14 |
$1K |
| 29700 |
|
50 |
49 |
$1K |
| 77065 |
Tomosynthesis, mammo |
13 |
13 |
$1K |
| 86762 |
|
185 |
185 |
$1K |
| 86709 |
|
441 |
440 |
$1K |
| 97161 |
|
30 |
15 |
$1K |
| 73521 |
|
43 |
43 |
$1K |
| 10060 |
|
66 |
65 |
$1K |
| 94760 |
|
186 |
178 |
$1K |
| 29075 |
|
18 |
13 |
$1K |
| 83540 |
|
1,212 |
1,182 |
$1K |
| 86430 |
|
418 |
414 |
$1K |
| Z4300 |
|
12 |
12 |
$1K |
| 97018 |
|
106 |
39 |
$1K |
| 86787 |
|
158 |
155 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
71 |
67 |
$1K |
| 86160 |
|
412 |
406 |
$1K |
| 31575 |
|
12 |
12 |
$1K |
| 82570 |
|
464 |
438 |
$949.81 |
| 90656 |
|
103 |
103 |
$944.00 |
| 82140 |
|
68 |
66 |
$939.91 |
| 86038 |
|
88 |
88 |
$907.57 |
| 73000 |
|
54 |
51 |
$892.93 |
| J1790 |
Injection, droperidol, up to 5 mg |
53 |
49 |
$880.46 |
| 93308 |
|
24 |
24 |
$821.49 |
| G0378 |
Hospital observation service, per hour |
341 |
288 |
$765.77 |
| 72081 |
|
27 |
26 |
$762.72 |
| 90480 |
|
19 |
19 |
$760.00 |
| 29125 |
|
79 |
77 |
$750.55 |
| 72072 |
|
26 |
26 |
$749.78 |
| 74019 |
|
27 |
26 |
$691.65 |
| 87521 |
Neg quan hep c or qual rna |
120 |
120 |
$671.29 |
| 86225 |
|
456 |
449 |
$633.90 |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
346 |
301 |
$633.86 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
46 |
44 |
$593.19 |
| 88313 |
|
14 |
14 |
$575.68 |
| 93299 |
|
28 |
28 |
$558.54 |
| 99188 |
|
27 |
27 |
$481.68 |
| 92591 |
|
13 |
13 |
$481.02 |
| 93242 |
|
24 |
24 |
$437.76 |
| 84703 |
|
52 |
51 |
$437.21 |
| 92579 |
|
13 |
13 |
$425.14 |
| 86592 |
|
289 |
286 |
$421.57 |
| 99201 |
|
12 |
12 |
$412.20 |
| 77080 |
|
12 |
12 |
$406.44 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
148 |
148 |
$371.71 |
| 85045 |
|
242 |
226 |
$329.21 |
| 82247 |
|
159 |
121 |
$305.74 |
| 84156 |
|
146 |
137 |
$299.52 |
| 83655 |
|
28 |
27 |
$285.88 |
| 87522 |
Neg quan hep c or qual rna |
134 |
133 |
$263.04 |
| 93246 |
|
14 |
14 |
$237.12 |
| 72200 |
|
12 |
12 |
$230.42 |
| 84153 |
|
139 |
138 |
$225.76 |
| 87338 |
|
287 |
287 |
$217.10 |
| 84466 |
|
180 |
179 |
$214.78 |
| 87045 |
|
58 |
58 |
$212.92 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
26 |
19 |
$196.04 |
| 83930 |
|
26 |
25 |
$185.54 |
| D1206 |
Topical application of fluoride varnish |
13 |
13 |
$180.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
29 |
28 |
$159.61 |
| 86039 |
|
27 |
27 |
$153.26 |
| 84403 |
|
54 |
54 |
$147.80 |
| 90677 |
|
12 |
12 |
$108.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
159 |
32 |
$107.75 |
| 85007 |
|
40 |
33 |
$107.14 |
| 87427 |
|
12 |
12 |
$105.85 |
| 86593 |
|
77 |
76 |
$101.43 |
| 85018 |
|
30 |
30 |
$100.50 |
| 29105 |
|
12 |
12 |
$93.60 |
| J1940 |
Injection, furosemide, up to 20 mg |
13 |
12 |
$83.57 |
| 87075 |
|
25 |
25 |
$74.00 |
| 82378 |
|
14 |
12 |
$72.00 |
| 99173 |
|
14 |
14 |
$66.85 |
| 82105 |
|
12 |
12 |
$57.76 |
| 82274 |
|
51 |
51 |
$57.15 |
| 82310 |
|
96 |
62 |
$49.20 |
| 82040 |
|
73 |
73 |
$49.02 |
| 80164 |
|
12 |
12 |
$43.98 |
| 84154 |
|
25 |
25 |
$22.00 |
| 84270 |
|
30 |
30 |
$20.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
44 |
44 |
$18.03 |
| 36415 |
Collection of venous blood by venipuncture |
645 |
595 |
$16.43 |
| 83520 |
|
56 |
56 |
$12.29 |
| 86200 |
|
215 |
213 |
$8.52 |
| G0071 |
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
406 |
361 |
$4.60 |
| 84155 |
|
174 |
174 |
$1.98 |
| J0606 |
Injection, etelcalcetide, 0.1 mg |
569 |
55 |
$0.00 |
| 00250 |
|
38 |
38 |
$0.00 |
| 84075 |
|
169 |
169 |
$0.00 |
| 87536 |
|
13 |
13 |
$0.00 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
233 |
232 |
$0.00 |
| 82172 |
|
42 |
42 |
$0.00 |
| 29705 |
|
14 |
14 |
$0.00 |
| 86147 |
|
12 |
12 |
$0.00 |